Growth Metrics

Bio-Techne (TECH) EPS (Weighted Average and Diluted) Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -25,782.97%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 41.33%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.33%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1.99%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.47%
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn -9.38%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -9.38%
Dec 31, 2025 -8.18%
Sep 30, 2025 -24.15%
Jun 30, 2025 -31.80%
Mar 31, 2025 -27.67%
Dec 31, 2024 -23.43%
Sep 30, 2024 -50.10%
Jun 30, 2024 28.38%
Mar 31, 2024 -34.83%
Dec 31, 2023 -47.13%
Sep 30, 2023 -27.98%
Jun 30, 2023 -32.26%
Mar 31, 2023 -22.39%
Dec 31, 2022 -53.18%
Sep 30, 2022 14.13%
Jun 30, 2022 -3.28%
Mar 31, 2022 -31.48%
Dec 31, 2021 2.88%
Sep 30, 2021 55.44%
Jun 30, 2021 -59.97%
Mar 31, 2021 29.14%
Dec 31, 2020 -3.76%
Sep 30, 2020 25.49%
Jun 30, 2020 25.99%
Mar 31, 2020 15.96%
Dec 31, 2019 147.17%
Sep 30, 2019 -9.55%
Jun 30, 2019 -15.25%
Mar 31, 2019 12.39%
Dec 31, 2018 -13.28%
Sep 30, 2018 -9.64%
Jun 30, 2018 15.19%
Mar 31, 2018 -7.17%
Dec 31, 2017 13.17%
Sep 30, 2017 -13.10%
Jun 30, 2017 0.45%
Mar 31, 2017 -11.46%
Dec 31, 2016 -33.50%
Sep 30, 2016 -12.25%
Jun 30, 2016 -3.59%
Mar 31, 2016 -3.45%
Dec 31, 2015 0.00%
Sep 30, 2015 -4.48%
Jun 30, 2015 -1.84%
Mar 31, 2015 -8.91%
Dec 31, 2014 8.33%
Sep 30, 2014 -4.72%
Jun 30, 2014 -1.33%
Mar 31, 2014 0.40%
Dec 31, 2013 -1.43%
Sep 30, 2013 1.39%
Jun 30, 2013 3.72%
Mar 31, 2013 1.14%
Dec 31, 2012 1.49%
Sep 30, 2012 -0.93%